Retraction to: Activation of AMPK improves lipopolysaccharide-induced dysfunction of the blood–brain barrier in mice (Brain Injury, (2015), 29, 6, (777-784), 10.3109/02699052.2015.1004746);Activation of AMPK improves lipopolysaccharide-induced dysfunction of the blood-brain barrier in mice

Brain Injury

Volumn 29, Issue 6, 2015, Pages 777-784

  Yu, Hai Ya ^a   Cai, Yu Bing ^a   Liu, Zhan ^a,b  

^a Department of Neurology People's Hospital of Xishui   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Ageing; AMPK; BBB; LPS; NAD(P)H oxidase; ROS

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; APOCYNIN; CLAUDIN 5; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPOPOLYSACCHARIDE; OCCLUDIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIPOPOLYSACCHARIDE-INDUCED SEPSIS; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BRAIN; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; ENDOTHELIUM CELL; ENZYMOLOGY; METABOLISM; PATHOLOGY; SEPSIS; VASCULARIZATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SEPSIS; TIGHT JUNCTION PROTEINS;

EID: 84937553997     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.1080/02699052.2018.1475604     Document Type: Erratum

References (28)

1. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacology Review 2005;57:173-185.
2. Matter K, Balda MS. Signalling to and from tight junctions. Nature Reviews Molecular & Cellular Biology 2003;4:225-236.
3. Feldman GJ, Mullin JM, Ryan MP. Occludin: Structure, function and regulation. Advanced Drug Delivery Review 2005;57:883-917.
4. Akrout N, Sharshar T, Annane D. Mechanisms of brain signaling during sepsis. Current Neuropharmacology 2009;7:296-301.
5. Dohgu S, Banks WA. Lipopolysaccharide-enhanced transcellular transport of hiv-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathway. Experimental Neurology 2008;210:740-749.
6. Nagyoszi P, Wilhelm I, Farkas AE, Fazakas C, Dung NT, Hasko J, Krizbai IA. Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochemistry International 2010;57: 556-564.
7. Singh AK, Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 2004;201: 197-207.
8. Veszelka S, Pasztoi M, Farkas AE, Krizbai I, Ngo TK, Niwa M, Abraham CS, Deli MA. Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages. Neurochemistry International 2007;50:219-228.
9. Wang S, Xu J, Song P, Viollet B, Zou MH. In vivo activation of amp-activated protein kinase attenuates diabetes-enhanced degradation of gtp cyclohydrolase i. Diabetes 2009;58:1893-1901.
10. Wang S, Zhang C, Zhang M, Liang B, Zhu H, Lee J, Viollet B, Xia L, Zhang Y, Zou MH. Activation of amp-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nature Medicine 2012;18:902-910.
11. Song P, Wang S, He C, Liang B, Viollet B, Zou MH. Ampkalpha2 deletion exacerbates neointima formation by upregulating skp2 in vascular smooth muscle cells. Circulation Research 2011;109: 1230-1239.
12. Wang S, Zhang M, Liang B, Xu J, Xie Z, Liu C, Viollet B, Yan D, Zou MH. Ampkalpha2 deletion causes aberrant expression and activation of nad(p)h oxidase and consequent endothelial dysfunction in vivo: Role of 26s proteasomes. Circulation Research 2010; 106:1117-1128.
13. Cardoso FL KA, Veszelka S, Palmela I, Tóth A, Brites D, Deli MA, Brito MA. Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells. PLoS One 2012;7:e35919.
14. Jin L, Nation RL, Li J, Nicolazzo JA. Species-dependent blood-brain barrier disruption of lipopolysaccharide: Amelioration by colistin in vitro and in vivo. Antimicrobial Agents and Chemotherapy 2013;57:4336-4342.
15. Wang S, Xu J, Song P, Wu Y, Zhang J, Chul Choi H, Zou MH. Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension 2008;52:484-490.
16. Liu C, Wu J, Zou MH. Activation of amp-activated protein kinase alleviates high-glucose-induced dysfunction of brain microvascular endothelial cell tight-junction dynamics. Free Radical Biology & Medicine 2012;53:1213-1221.
17. Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in blood-brain barrier: An overview of structure, regulation, and regulator substances. CNS Neuroscience & Therapeutics 2012;18: 609-615.
18. Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, et al. Reactive oxygen species alter brain endothelial tight junction dynamics via rhoa, pi3 kinase, and pkb signaling. FASEB Journal 2007;21:3666-3676.
19. Song P, Zou MH. Regulation of nad(p)h oxidases by ampk in cardiovascular systems. Free Radical Biology & Medicine 2012;52: 1607-1619.
20. Salminen A, Hyttinen JM, Kaarniranta K. Amp-activated protein kinase inhibits nf-kappab signaling and inflammation: Impact on healthspan and lifespan. Journal of Molecular Medicine (Berlin) 2011;89:667-676.
21. Pasquier F, Boulogne A, Leys D, Fontaine P. Diabetes mellitus and dementia. Diabetes & Metabolism 2006;32:403-414.
22. Ristow M. Neurodegenerative disorders associated with diabetes mellitus. Journal of Molecular Medicine 2004;82: 510-529.
23. Harford-Wright E, Lewis KM, Ghabriel MN, Vink R. Treatment with the nk1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors. PloS One 2014;9:e97002.
24. Castanares-Zapatero D, Bouleti C, Mathivet T, Gerber B, Oury C, Bertrand L, Vanoverschelde J, Laterre P, Horman S, Beauloye C. Amp-activated protein kinase preserves endothelial tight junctions in the coronary microcirculation during sepsis. Critial Care 2012;16:30.
25. Castanares-Zapatero D, Bouleti C, Sommereyns C, Gerber B, Lecut C, Mathivet T, Horckmans M, Communi D, Foretz M, Vanoverschelde JL, et al. Connection between cardiac vascular permeability, myocardial edema, and inflammation during sepsis: Role of the alpha1amp-activated protein kinase isoform. Critical Care Medicine 2013;41:e411-422.
26. Wang S, Song P, Zou MH. Amp-activated protein kinase, stress responses and cardiovascular diseases. Clinical Science (London) 2012;122:555-573.
27. Xie Z, Zhang J, Wu J, Viollet B, Zou MH. Upregulation of mitochondrial uncoupling protein-2 by the amp-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes 2008;57:3222-3230.
28. Nishikawa T, Araki E. Impact of mitochondrial ros production in the pathogenesis of diabetes mellitus and its complications. Antioxidants & Redox Signaling 2007;9:343-353.